SK bioscienceLtd Management
Management criteria checks 1/4
SK bioscienceLtd's CEO is Jae-Yong Ahn, appointed in Mar 2021, has a tenure of 3.5 years. directly owns 0.057% of the company’s shares, worth ₩2.46B. The average tenure of the management team and the board of directors is 1.9 years and 3.7 years respectively.
Key information
Jae-Yong Ahn
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.5yrs |
| CEO ownership | 0.06% |
| Management average tenure | 1.9yrs |
| Board average tenure | 3.7yrs |
Recent management updates
CEO
Jae-Yong Ahn (57 yo)
3.5yrs
Tenure
Mr. Jae-Yong Ahn is the Chief Executive Officer and President of SK bioscience Co.,Ltd since March 2021 and served as its Chairman since March 2021. He serves as Executive Officer and Director of VAX Busi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.5yrs | no data | 0.057% ₩ 2.5b | |
| Executive Vice President of Vaccine R&D Strategy & External Innovation | 1.9yrs | no data | no data | |
| Head of Global Clinical Development & Regulatory Affairs | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
Experienced Management: A302440's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | no data | no data | 0.057% ₩ 2.5b | |
| Executive Director | 3.5yrs | no data | 0.057% ₩ 2.5b | |
| Independent Chairman of the Board | 3.5yrs | no data | no data | |
| Independent Outside Director | 3.9yrs | no data | no data | |
| Independent Outside Director | 3.9yrs | no data | no data |
3.7yrs
Average Tenure
Experienced Board: A302440's board of directors are considered experienced (3.7 years average tenure).